1. Most Discussed
  2. Gainers & Losers
OBJ 2.8¢

Analgesics GSK...Love it

  1. combi

    3,337 Posts.
    2
    Analgesics programme is looking very interesting and now the tie up with GSK is likely expanding to Novartis, NICE ONE.

    With phase I and II formulation, development and evaluations successfully completed they are well on their way to creating a massive ongoing opportunity with this Analgesics.

    For me Body Guard is extremely exciting and the Analgesic opportunity has moved from being very interesting to extremely exciting.

    Both have huge revenue/volume potential!!!

    Their is now no doubt that OBJ is going to prosper significantly from its technology foray into cosmetic industry.

    It was a shame about the Toothbrush, thank God we are not a one product show; and P&G are going gang busters with an expanding portfolio opportunity, they must love what they are seeing.

    All IMO of course.

DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top

Thank you for visiting HotCopper

We have detected that you are running ad blocking software.


HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.